相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Rifaximin Therapy for Patients with Irritable Bowel Syndrome without Constipation.
Mark Pimentel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review
P. Moayyedi et al.
GUT (2010)
Pathogenesis of IBs: role of inflammation, immunity and neuroimmune interactions
Lena Ohman et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2010)
Effect of mesalazine on mucosal immune biomarkers in irritable bowel syndrome: a randomized controlled proof-of-concept study
R. Corinaldesi et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Development and application of the human intestinal tract chip, a phylogenetic microarray: analysis of universally conserved phylotypes in the abundant microbiota of young and elderly adults
Mirjana Rajilic-Stojanovic et al.
ENVIRONMENTAL MICROBIOLOGY (2009)
Effects of Mesalamine (5-Aminosalicylic Acid) on Bacterial Gene Expression
Jaime Kaufman et al.
INFLAMMATORY BOWEL DISEASES (2009)
Review article: the psychoneuroimmunology of irritable bowel syndrome - an exploration of interactions between psychological, neurological and immunological observations
N. Arebi et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Gastrointestinal microbiota in irritable bowel syndrome: Their role in its pathogenesis and treatment
Gareth C. Parkes et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Irritable bowel syndrome - the new inflammatory bowel disease?
Robin Spiller
CLINICAL MEDICINE (2008)
Increased faecal serine protease activity in diarrhoeic IBS patients: a colonic lumenal factor impairing colonic permeability and sensitivity
K. Gecse et al.
GUT (2008)
Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy
Qiong Wang et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2007)
MMX Multi Matrix System® mesalazine for the induction of remission in patients with mild-to-moderate ulcerative colitis:: a combined analysis of two randomized, double-blind, placebo-controlled trials
W. J. Sandborn et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects
Anna Kassinen et al.
GASTROENTEROLOGY (2007)
Role for protease activity in visceral pain in irritable bowel syndrome
Nicolas Cenac et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome
Giovanni Barbara et al.
GASTROENTEROLOGY (2007)
Azathioprine and mesalazine-induced effects on the mucosal flora in patients with IBD colitis
Alexander Swidsinski et al.
INFLAMMATORY BOWEL DISEASES (2007)
Drug insight: aminosalicylates for the treatment of IBD
Ole H. Nielsen et al.
NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY (2007)
Statistical methods for characterizing diversity of microbial communities by analysis of terminal restriction fragment length polymorphisms of 16S rRNA genes
Z Abdo et al.
ENVIRONMENTAL MICROBIOLOGY (2006)
Functional bowel disorders
George F. Longstreth et al.
GASTROENTEROLOGY (2006)
Diversity of the human intestinal microbial flora
PB Eckburg et al.
SCIENCE (2005)
A major role for proteolytic activity and proteinase-activated receptor-2 in the pathogenesis of infectious colitis
KK Hansen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Clinical relevance of proteinase activated receptors (PARs) in the gut
N Vergnolle
GUT (2005)
Composition and temporal stability of gastrointestinal microbiota in irritable bowel syndrome -: a longitudinal study in IBS and control subjects
J Mättö et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2005)
Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR
E Malinen et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
Mesalamine delivery systems: do they really make much difference?
AI Qureshi et al.
ADVANCED DRUG DELIVERY REVIEWS (2005)
Dysbiosis in inflammatory bowel disease
CP Tamboli et al.
GUT (2004)
Randomized, double-blind, placebo-controlled trial of prednisolone in post-infectious irritable bowel syndrome
SP Dunlop et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
AGA technical review on irritable bowel syndrome
DA Drossman et al.
GASTROENTEROLOGY (2002)
American gastroenterological association medical position statement: Irritable bowel syndrome
GASTROENTEROLOGY (2002)
Mucosa-associated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from feces
EG Zoetendal et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2002)
DNA isolation Protocols affect the detection limit of PCR approaches of bacteria in samples from the human gastrointestinal tract
EG Zoetendal et al.
SYSTEMATIC AND APPLIED MICROBIOLOGY (2001)
Terminal restriction fragment length polymorphism analysis program, a web-based research tool for microbial community analysis
TL Marsh et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2000)
分享论文
